Add-on Acquisition • Life Science

Myonexus Therapeutics Acquires SaveWay

On April 10, 2024, Myonexus Therapeutics acquired life science company SaveWay

Acquisition Context

This is Myonexus Therapeutics’ 1st transaction in the Life Science sector.
This is Myonexus Therapeutics’ 1st transaction in the United States.
This is Myonexus Therapeutics’ 1st transaction in Delaware.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	April 10, 2024
Target	SaveWay
Sector	Life Science
Buyer(s)	Myonexus Therapeutics
Deal Type	Add-on Acquisition

Target Company

SaveWay

Newark, Delaware, United States

SaveWay is a local community resource for affordable, non-sterile compounded medications. The Company offers custom sterile and non-sterile compounded medications that can be personalized based on dose or delivery system. SaveWay was founded in 2001 and is based in Newark, Delaware.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Myonexus Therapeutics

New Albany, Ohio, United States

Category	Company
Founded	2017
Sector	Life Science

DESCRIPTION

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a provider in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics was founded in 2017 and is based in New Albany, Ohio.

Deal Context for Buyer	#
Overall	2 of 2
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Delaware	1 of 1
Country: United States	1 of 1
Year: 2024	2 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2024-03-15	Creapharm’s Clinical & Commercial Packaging and Bioservices Business Reims, France Creapharm’s Clinical & Commercial Packaging and Bioservices Business provides clinical packaging and distribution to commercial packaging and advanced therapy medicinal products (ATMPs) supply chain management.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2024-03-15

Creapharm’s Clinical & Commercial Packaging and Bioservices Business

Reims, France

Creapharm’s Clinical & Commercial Packaging and Bioservices Business provides clinical packaging and distribution to commercial packaging and advanced therapy medicinal products (ATMPs) supply chain management.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Delaware M&A - United States M&A - 2024 M&A